Shares of Context Therapeutics Inc. rose over 7% in Wednesday's pre-market trading after JMP Securities initiated coverage ...
Allogene Therapeutics Inc (ALLO) stock saw a modest uptick, ending the day at $2.35 which represents a slight increase of $0.19 or 8.80% from the prior close of $2.16. The stock opened at $2.15 and ...
Macquarie has recently initiated Agilon Health Inc (AGL) stock to Neutral rating, as announced on December 16, 2024, according to Finviz. Earlier, on December 11, 2024, Bernstein had initiated the ...